相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeted Liquid Biopsy Using Irradiation to Facilitate the Release of Cell-Free DNA from a Spatially Aimed Tumor Tissue
Jae Myoung Noh et al.
CANCER RESEARCH AND TREATMENT (2022)
Clinical Practice Guidelines for Pre-Analytical Procedures of Plasma Epidermal Growth Factor Receptor Variant Testing
Saeam Shin et al.
ANNALS OF LABORATORY MEDICINE (2022)
p16 methylation is a potential predictive marker for abemaciclib sensitivity in gastric cancer
Hyun Joo Bae et al.
BIOCHEMICAL PHARMACOLOGY (2021)
Development and validation of a targeted sequencing panel for application to treatment-refractory solid tumor.
Woo Sun Kwon et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Pan-cancer circulating tumor DNA detection in over 10,000 Chinese patients
Yongliang Zhang et al.
NATURE COMMUNICATIONS (2021)
Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology
Ira W. Deveson et al.
NATURE BIOTECHNOLOGY (2021)
White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer
Alessandro Leal et al.
NATURE COMMUNICATIONS (2020)
Tumor Mutational Burden Determined by Panel Sequencing Predicts Survival After Immunotherapy in Patients With Advanced Gastric Cancer
Jinchul Kim et al.
FRONTIERS IN ONCOLOGY (2020)
Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin
Ryan Woodhouse et al.
PLOS ONE (2020)
EGFR Mutations in Cell-free Plasma DNA from Patients with Advanced Lung Adenocarcinoma: Improved Detection by Droplet Digital PCR
Anna Buder et al.
TARGETED ONCOLOGY (2019)
Assessment of Blood Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Patients With Non-Small Cell Lung Cancer With Use of a Next-Generation Sequencing Cancer Gene Panel
Zhijie Wang et al.
JAMA ONCOLOGY (2019)
High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants
Pedram Razavi et al.
NATURE MEDICINE (2019)
Biological background of the genomic variations of cf-DNA in healthy individuals
J. Liu et al.
ANNALS OF ONCOLOGY (2019)
Measuring Tumor Mutational Burden (TMB) in Plasma from mCRPC Patients Using Two Commercial NGS Assays
Ping Qiu et al.
SCIENTIFIC REPORTS (2019)
Molecular Profiling of Patients with Pancreatic Cancer: Initial Results from the Know Your Tumor Initiative
Michael J. Pishvaian et al.
CLINICAL CANCER RESEARCH (2018)
Forty-nine gastric cancer cell lines with integrative genomic profiling for development of c-MET inhibitor
Hyun Jeong Kim et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
The Tumor Mutational Burden of Chinese Advanced Cancer Patients Estimated by a 381-cancer-gene Panel
Wu Zhuang et al.
JOURNAL OF CANCER (2018)
131PDevelopment and analytical validation of a plasma-based tumor mutational burden (TMB) score from next-generation sequencing panels
K Quinn et al.
ANNALS OF ONCOLOGY (2018)
The amount of activating EGFR mutations in circulating cell-free DNA is a marker to monitor osimertinib response
Marzia Del Re et al.
BRITISH JOURNAL OF CANCER (2018)
Maftools: efficient and comprehensive analysis of somatic variants in cancer
Anand Mayakonda et al.
GENOME RESEARCH (2018)
Application of Cell-free DNA Analysis to Cancer Treatment
Ryan B. Corcoran et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Guidelines for Validation of Next-Generation Sequencing-Based Oncology Panels A Joint Consensus Recommendation of the Association for Molecular Pathology and College of American Pathologists
Lawrence J. Jennings et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2017)
Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists
Marilyn M. Li et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2017)
Integrated digital error suppression for improved detection of circulating tumor DNA
Aaron M. Newman et al.
NATURE BIOTECHNOLOGY (2016)
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Sue Richards et al.
GENETICS IN MEDICINE (2015)
Toward better understanding of artifacts in variant calling from high-coverage samples
Heng Li
BIOINFORMATICS (2014)
Comprehensive molecular characterization of gastric adenocarcinoma
Adam J. Bass et al.
NATURE (2014)
Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer
Kai Wang et al.
NATURE GENETICS (2014)
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
Aaron M. Newman et al.
NATURE MEDICINE (2014)
Detecting ultralow-frequency mutations by Duplex Sequencing
Scott R. Kennedy et al.
NATURE PROTOCOLS (2014)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
A robust model for read count data in exome sequencing experiments and implications for copy number variant calling
Vincent Plagnol et al.
BIOINFORMATICS (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Detection and quantification of rare mutations with massively parallel sequencing
Isaac Kinde et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
分享论文
